In this study, BsAbs with the ability to simultaneously bind to CD3 and tumor antigens (prostate-specific membrane antigen, PSMA) were generated by genetically fusing an anti-CD3 antibody with an anti-PSMA antibody. Here, FOLH1 is linked to neoplasm.